DK1216256T3 - Makrolid-antibiotika og behandling af pasteurellosis - Google Patents

Makrolid-antibiotika og behandling af pasteurellosis

Info

Publication number
DK1216256T3
DK1216256T3 DK00955002T DK00955002T DK1216256T3 DK 1216256 T3 DK1216256 T3 DK 1216256T3 DK 00955002 T DK00955002 T DK 00955002T DK 00955002 T DK00955002 T DK 00955002T DK 1216256 T3 DK1216256 T3 DK 1216256T3
Authority
DK
Denmark
Prior art keywords
pasteurellosis
treatment
macrolide antibiotics
derivatives
peperidino
Prior art date
Application number
DK00955002T
Other languages
Danish (da)
English (en)
Inventor
Toshiaki Miyake
Tomohisa Takita
Masa Hamada
Tomio Takeuchi
Sumio Umezawa
Original Assignee
Zaidan Hojin Biseibutsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaidan Hojin Biseibutsu filed Critical Zaidan Hojin Biseibutsu
Application granted granted Critical
Publication of DK1216256T3 publication Critical patent/DK1216256T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK00955002T 1999-08-30 2000-08-24 Makrolid-antibiotika og behandling af pasteurellosis DK1216256T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24328699 1999-08-30
PCT/JP2000/005721 WO2001016148A1 (en) 1999-08-30 2000-08-24 Macrolide antibiotics and treatment of pasteurellosis

Publications (1)

Publication Number Publication Date
DK1216256T3 true DK1216256T3 (da) 2004-06-21

Family

ID=17101600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00955002T DK1216256T3 (da) 1999-08-30 2000-08-24 Makrolid-antibiotika og behandling af pasteurellosis

Country Status (13)

Country Link
US (1) US6514946B1 (Direct)
EP (1) EP1216256B1 (Direct)
JP (1) JP4573411B2 (Direct)
AT (1) ATE261450T1 (Direct)
AU (1) AU763732B2 (Direct)
BE (1) BE2011C037I2 (Direct)
CA (1) CA2391834C (Direct)
DE (2) DE60008895T2 (Direct)
DK (1) DK1216256T3 (Direct)
ES (1) ES2213597T3 (Direct)
FR (1) FR11C0037I2 (Direct)
PT (1) PT1216256E (Direct)
WO (1) WO2001016148A1 (Direct)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006078032A1 (ja) 2005-01-24 2006-07-27 Microbial Chemistry Research Foundation 抗ペニシリン耐性肺炎球菌剤及び新規１６員環マクロライド誘導体
US9148795B2 (en) * 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
NZ574193A (en) * 2006-07-28 2011-09-30 Intervet Int Bv Macrolide synthesis process
KR101456308B1 (ko) 2006-07-28 2014-11-03 인터벳 인터내셔널 비.브이. 마크롤라이드 합성 방법
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法
CN102863487B (zh) * 2012-10-08 2014-11-05 齐鲁动物保健品有限公司 20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的制备方法
DK2999707T3 (en) * 2013-05-23 2018-06-06 Bayer Animal Health Gmbh Tylosin derivatives and process for their preparation.
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN104788519B (zh) * 2014-01-22 2018-07-20 镇江威特药业有限责任公司 十六元环三胺内酯衍生物及其应用
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104558076A (zh) * 2015-02-10 2015-04-29 上海皓元化学科技有限公司 一种泰地罗新的制备方法及其中间体化合物
US10287275B2 (en) * 2015-04-16 2019-05-14 Victor Pharma Co., Ltd. Zhenjiang 16-member triamilide derivatives and uses thereof
CN105440093A (zh) * 2015-11-17 2016-03-30 宁夏泰瑞制药股份有限公司 一种泰地罗新的合成方法
CN105919933A (zh) * 2016-06-13 2016-09-07 上海同仁药业股份有限公司 泰地罗新注射液及其制备方法
CN106420600A (zh) * 2016-09-21 2017-02-22 中国水产科学研究院珠江水产研究所 一种替米考星注射用原位凝胶及其制备方法
CN108264530A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 20,23-二卤代-5-o-碳霉胺糖基-泰乐内酯及其合成方法和应用
CN108264529A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 一种20,23-二哌啶-5-o-碳霉胺糖基-泰乐内酯的合成方法
EP4255445B1 (en) 2020-12-03 2025-05-14 Intervet International B.V. Tildipirosin for the treatment of foot rot
CN116731096B (zh) * 2023-06-10 2025-03-04 中国兽医药品监察所 20-醛基-23-哌啶基-5-o-碳霉胺糖基-泰乐内酯及其合成方法及它的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454314A (en) 1982-08-02 1984-06-12 Pfizer Inc. Antibacterial mycaminosyl tylonolide and related macrolide derivatives
JPS5951299A (ja) * 1982-09-17 1984-03-24 Microbial Chem Res Found ２３−デオキシ−２０−ジヒドロ−マイカミノシルタイロノライド誘導体
JPS59225199A (ja) * 1983-02-10 1984-12-18 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換アミノマイカミノシルレロノライド
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4629786A (en) 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
ZA841277B (en) * 1983-02-28 1985-09-25 Lilly Co Eli C-20-and c-23-modified macrolide derivatives
JPS59181299A (ja) * 1983-03-31 1984-10-15 Microbial Chem Res Found ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド
JPS59227897A (ja) * 1983-06-10 1984-12-21 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換−マイカミノシルレロノライド
US4604380A (en) * 1985-01-18 1986-08-05 Eli Lilly And Company C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use
TW226373B (Direct) * 1992-07-15 1994-07-11 Pfizer

Also Published As

Publication number Publication date
JP4573411B2 (ja) 2010-11-04
DE60008895D1 (de) 2004-04-15
FR11C0037I2 (fr) 2012-06-22
FR11C0037I1 (Direct) 2011-10-14
EP1216256B1 (en) 2004-03-10
JP2001139592A (ja) 2001-05-22
US6514946B1 (en) 2003-02-04
EP1216256A1 (en) 2002-06-26
ATE261450T1 (de) 2004-03-15
PT1216256E (pt) 2004-07-30
AU763732B2 (en) 2003-07-31
ES2213597T3 (es) 2004-09-01
DE60008895T2 (de) 2005-01-20
CA2391834C (en) 2008-08-05
DE122011100013I1 (de) 2011-09-15
BE2011C037I2 (Direct) 2019-10-16
WO2001016148A1 (en) 2001-03-08
CA2391834A1 (en) 2001-03-08
AU6729400A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
DK0941998T3 (da) 3,6-ketalmakrolidantibiotika
NO20020407D0 (no) Hydrogenerte blokkpolymerer med elastisitet og gjenstander fremstilt derav
NO962592D0 (no) PH-modifiserte polymerblandinger med ökt biologisk nedbrytbarhet
EE03680B1 (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
BR9915457B1 (pt) composições de moldagem, uso e artigo.
BR9909994A (pt) Quinolinas usadas como inibidores de mrs e bactericidas
DK1131331T3 (da) 13-leddede azalider og deres anvendelse som antibiotiske midler
NO20012155D0 (no) Nye makrolid-antibiotika
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
DK0755978T3 (da) Polyoxyalkylen-blokcopolymerer, deres fremstilling og anvendelse som smøremidler
DE69108020D1 (de) Polymerzusammensetzung, und daraus hergestellte Formkörper.
DE69933548D1 (de) Ligatur-system mit grösserer dehnbarkeit, längerer haltbarkeit und grösseren ligatur-eigenschaften
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
DE60005349D1 (de) Dithiepino[6,5-b]pyridine und diese verwendete zusamensetzungen und methode
MX9204338A (es) Metodos de tratamiento con antimicrobianos y composiciones antimicrobianas.
FR2784379B1 (fr) Derives de quinazolinedione, leurs preparations et leurs applications en therapeutique
ATE222262T1 (de) Antibiotisch wirksame stalobacine
NO20005157L (no) Regulerbar genekspresjon i gram-positive bakterier
IT1311558B1 (it) Banco espositore con ripiani regolabili.
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas
IT1304822B1 (it) Composizione anticrittogamica particolarmente idonea per trattareinfezioni fungine e batteriche delle piante.
ITMI913397A1 (it) Derivati chinolonici, procedimento di preparazione ed impiego come antibatterici.